Despite incontrovertible evidence of the harmful effects of endocrine disruptors, a sound public health policy is still absent. Meanwhile, the press has revealed the hindering role of industry lobbyists and conflicts of interest among members of the regulatory bodies. Here, we identify another hindrance; one that stems from current experimental research practices.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
EPMA Journal Open Access 07 October 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Soto, A. M., Longo, G. & Noble, D. Preface to “From the century of the genome to the century of the organism: new theoretical approaches”. Prog. Biophys. Mol. Biol. 122, 1–3 (2016).
Noble, D. Dance to the Tune of Life: Biological Relativity (Cambridge Univ. Press, Cambridge, 2016).
Beausoleil, C. et al. Regulatory identification of BPA as an endocrine disruptor: context and methodology. Mol. Cell Endocrinol. https://doi.org/10.1016/j.mce.2018.02.001 (2018).
Longo, G., Miquel, P.-A., Sonnenschein, C. & Soto, A. M. Is information a proper observable for biological organization? Prog. Biophys. Mol. Biol. 109, 108–114 (2012).
Hill, A. B. The environment and disease: association or causation? Proc. R. Soc. Med. 58, 295–300 (1965).
Acknowledgements
This work was conducted as part of the research project “Addressing biological organization in the post-genomic era” which was supported by the International Blaise Pascal Chairs, Region Ile de France (A.M.S: Pascal Chair 2013–2015). Additional support to AMS was provided by Grant R01ES08314 from the U.S. National Institute of Environmental Health Sciences. The funders had no role in the content, decision to publish or preparation of the manuscript. The authors are grateful to C. Schaeberle and N. Hasan for their critical input.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Soto, A.M., Sonnenschein, C. Endocrine disruptors — putting the mechanistic cart before the phenomenological horse. Nat Rev Endocrinol 14, 317–318 (2018). https://doi.org/10.1038/s41574-018-0003-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-018-0003-7
This article is cited by
-
From Wingspread to CLARITY: a personal trajectory
Nature Reviews Endocrinology (2021)
-
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
EPMA Journal (2021)